Replies to post #22897 on CytoSorbents Corporation (CTSO)

[Jdizzy]

CTSO guided second half 2020 sales to be less than first half sales. This is because they have seen an explosion of demand due to COVID-19. Management doesn’t believe this demand is sustainable... however it’s not a big stretch to believe the COVID-19 demand will transfer to massive growth in demand for other indications. In other words, I believe $15M+ revenue per quarter will become the baseline for future growth as other catalysts come online. If this materializes then the stock price is very undervalued. There is some risk here at this price (e.g. REMOVE data readout) but risk/reward is still very favorable.